LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,518 | -17.3% | 49,024 | -0.5% | 0.01% | -11.1% |
| Q2 2023 | $3,552,295 | -5.7% | 49,269 | -3.8% | 0.01% | 0.0% |
| Q1 2023 | $3,768,332 | +104.6% | 51,228 | +85.8% | 0.01% | +80.0% |
| Q4 2022 | $1,841,476 | +184047.6% | 27,567 | +250509.1% | 0.01% | – |
| Q3 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -99.9% | 11 | -99.8% | 0.00% | -100.0% |
| Q1 2022 | $770,000 | -45.8% | 6,847 | -25.5% | 0.00% | -33.3% |
| Q4 2021 | $1,420,000 | +10.9% | 9,193 | -0.0% | 0.00% | +50.0% |
| Q3 2021 | $1,281,000 | -85.1% | 9,196 | -85.9% | 0.00% | -87.5% |
| Q2 2021 | $8,577,000 | +332.7% | 65,377 | +402.9% | 0.02% | +300.0% |
| Q1 2021 | $1,982,000 | -44.9% | 13,000 | -64.1% | 0.00% | -42.9% |
| Q4 2020 | $3,597,000 | +61.4% | 36,173 | +54.7% | 0.01% | +40.0% |
| Q3 2020 | $2,229,000 | +821.1% | 23,384 | +978.6% | 0.01% | +400.0% |
| Q2 2020 | $242,000 | +53.2% | 2,168 | -0.4% | 0.00% | – |
| Q1 2020 | $158,000 | -42.8% | 2,177 | -17.8% | 0.00% | -100.0% |
| Q4 2019 | $276,000 | -15.9% | 2,647 | -19.6% | 0.00% | 0.0% |
| Q3 2019 | $328,000 | -26.0% | 3,293 | -15.2% | 0.00% | 0.0% |
| Q2 2019 | $443,000 | -52.5% | 3,883 | -47.6% | 0.00% | -50.0% |
| Q1 2019 | $932,000 | -4.6% | 7,413 | +3.0% | 0.00% | -33.3% |
| Q4 2018 | $977,000 | -87.5% | 7,197 | -74.7% | 0.00% | -83.3% |
| Q3 2018 | $7,802,000 | -42.6% | 28,423 | -56.7% | 0.02% | -55.0% |
| Q2 2018 | $13,598,000 | +393.4% | 65,639 | +293.4% | 0.04% | +400.0% |
| Q1 2018 | $2,756,000 | -10.9% | 16,686 | -26.1% | 0.01% | -11.1% |
| Q4 2017 | $3,093,000 | +59.1% | 22,587 | +58.2% | 0.01% | +50.0% |
| Q3 2017 | $1,944,000 | +251.5% | 14,277 | +208.1% | 0.01% | +200.0% |
| Q2 2016 | $553,000 | +18333.3% | 4,634 | +14848.4% | 0.00% | – |
| Q1 2016 | $3,000 | -97.6% | 31 | -97.9% | 0.00% | – |
| Q3 2015 | $125,000 | +66.7% | 1,455 | +95.6% | 0.00% | – |
| Q2 2015 | $75,000 | +2400.0% | 744 | +1228.6% | 0.00% | – |
| Q4 2014 | $3,000 | -99.8% | 56 | -99.8% | 0.00% | -100.0% |
| Q3 2014 | $1,202,000 | -8.4% | 25,579 | +21.4% | 0.00% | 0.0% |
| Q2 2014 | $1,312,000 | +72.4% | 21,070 | +86.2% | 0.00% | +33.3% |
| Q1 2014 | $761,000 | +1035.8% | 11,314 | +786.7% | 0.00% | – |
| Q4 2013 | $67,000 | -27.2% | 1,276 | -39.9% | 0.00% | – |
| Q3 2013 | $92,000 | -30.8% | 2,124 | -40.1% | 0.00% | -100.0% |
| Q2 2013 | $133,000 | – | 3,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |